{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T12:16:16Z","timestamp":1780575376833,"version":"3.54.1"},"reference-count":72,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Turkish Neurosurgical Society"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","injuryjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Injury"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.injury.2019.08.036","type":"journal-article","created":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T11:06:59Z","timestamp":1566299219000},"page":"1586-1592","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Neuroprotective effects of mildronate in a rat model of traumatic brain injury"],"prefix":"10.1016","volume":"50","author":[{"given":"Dilan","family":"Demir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9889-9955","authenticated-orcid":false,"given":"P\u0131nar","family":"Kuru Bekta\u015fo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T\u00fcrkan","family":"Koyuncuo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cansu","family":"Kandemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilek","family":"Akak\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4760-3306","authenticated-orcid":false,"given":"Meral","family":"Y\u00fcksel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erhan","family":"\u00c7eliko\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berrak \u00c7.","family":"Ye\u011fen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1500-6184","authenticated-orcid":false,"given":"Bora","family":"G\u00fcrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.injury.2019.08.036_bib0005","doi-asserted-by":"crossref","first-page":"e53376","DOI":"10.1371\/journal.pone.0053376","article-title":"Long-term upregulation of inflammation and suppression of cell proliferation in the brain of adult rats exposed to traumatic brain injury using the controlled cortical impact model","volume":"8","author":"Acosta","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.injury.2019.08.036_bib0010","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1177\/0271678X17701460","article-title":"Response of the cerebral vasculature following traumatic brain injury","volume":"37","author":"Salehi","year":"2017","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.injury.2019.08.036_bib0015","first-page":"97","article-title":"Neuroinflammatory responses to traumatic brain injury: etiology, clinical consequences, and therapeutic opportunities","volume":"11","author":"Lozano","year":"2015","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"4","key":"10.1016\/j.injury.2019.08.036_bib0020","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s12975-011-0126-9","article-title":"A neurovascular perspective for long-term changes after brain trauma","volume":"2","author":"Pop","year":"2011","journal-title":"Transl Stroke Res"},{"issue":"3","key":"10.1016\/j.injury.2019.08.036_bib0025","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3171\/jns.1992.77.3.0360","article-title":"Ultra-early evaluation of regional cerebral blood flow in severely head-injured patients using xenon enhanced computerized tomography","volume":"77","author":"Bouma","year":"1992","journal-title":"J Neurosurg"},{"issue":"9","key":"10.1016\/j.injury.2019.08.036_bib0030","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1089\/neu.2005.22.955","article-title":"Monitoring of cerebral blood flow and metabolism in traumatic brain injury","volume":"22","author":"Soustiel","year":"2005","journal-title":"J Neurotrauma"},{"issue":"10","key":"10.1016\/j.injury.2019.08.036_bib0035","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1038\/jcbfm.2014.131","article-title":"Capillary transit time heterogeneity and flow-metabolism coupling after traumatic brain injury","volume":"34","author":"\u00d8stergaard","year":"2014","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"10.1016\/j.injury.2019.08.036_bib0040","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.neulet.2009.12.055","article-title":"Neuroprotective properties of mildronat, a mitochondria-targeted small molecule","volume":"470","author":"Pupure","year":"2010","journal-title":"Neurosci Lett"},{"issue":"6","key":"10.1016\/j.injury.2019.08.036_bib0045","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1050-1738(02)00175-5","article-title":"Mildronat: cardioprotective action through carnitine lowering effect","volume":"12","author":"Dambrova","year":"2002","journal-title":"Trends Cardiovasc Med"},{"issue":"2","key":"10.1016\/j.injury.2019.08.036_bib0050","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0006-2952(88)90717-4","article-title":"3-(2,2,2-Trimethylhydrazinium) propionate (THP)--a novel gamma-butyrobetaine hydroxylase inhibitor with cardioprotective properties","volume":"37","author":"Simkhovich","year":"1988","journal-title":"Biochem Pharmacol"},{"issue":"7","key":"10.1016\/j.injury.2019.08.036_bib0055","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00059-002-2428-x","article-title":"The use of partial fatty acid oxidation inhibitors for metabolic therapy of angina pectoris and heart failure","volume":"27","author":"Rupp","year":"2002","journal-title":"Herz"},{"issue":"2","key":"10.1016\/j.injury.2019.08.036_bib0060","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1527-3458.2005.tb00267.x","article-title":"Mildronat: an antiischemic drug for neurological indications","volume":"11","author":"Sjakste","year":"2005","journal-title":"CNS Drug Rev"},{"issue":"1-2","key":"10.1016\/j.injury.2019.08.036_bib0065","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/0006-8993(92)91117-W","article-title":"Preservation of energy metabolites by carnitine in the mouse brain under ischemia","volume":"590","author":"Matsuoka","year":"1992","journal-title":"Brain Res"},{"issue":"5-6","key":"10.1016\/j.injury.2019.08.036_bib0070","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/FBP.0b013e32833d5a59","article-title":"Mildronat exerts acute anticonvulsant and antihypnotic effects","volume":"21","author":"Zvejniece","year":"2010","journal-title":"Behav Pharmacol"},{"issue":"1","key":"10.1016\/j.injury.2019.08.036_bib0075","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bbr.2011.03.027","article-title":"Mildronat treatment improves functional recovery following middle cerebral artery occlusion in rats","volume":"222","author":"Svalbe","year":"2011","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.injury.2019.08.036_bib0080","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejphar.2013.12.006","article-title":"Mildronat, the inhibitor of L-carnitine transport, induces brain mitochondrial uncoupling and protects against anoxia-reoxygenation","volume":"723","author":"Makrecka","year":"2014","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"10.1016\/j.injury.2019.08.036_bib0085","first-page":"301","article-title":"Mildronat and its neuroregulatory mechanisms: targeting the mitochondria, neuroinflammation, and protein expression","volume":"49","author":"Klusa","year":"2013","journal-title":"Medicina (Kaunas)"},{"issue":"10","key":"10.1016\/j.injury.2019.08.036_bib0090","first-page":"552","article-title":"Mildronat as a regulator of protein expression in a rat model of Parkinson\u2019s disease","volume":"47","author":"Isajevs","year":"2011","journal-title":"Medicina (Kaunas)"},{"issue":"2","key":"10.1016\/j.injury.2019.08.036_bib0095","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.neulet.2009.12.055","article-title":"Neuroprotective properties of mildronat, a mitochondria-targeted small molecule","volume":"470","author":"Pupure","year":"2010","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.injury.2019.08.036_bib0100","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.pbb.2013.03.012","article-title":"Mildronat enhances learning\/memory and changes hippocampal protein expression in trained rats","volume":"106","author":"Klusa","year":"2013","journal-title":"Pharmacol Biochem Behav"},{"issue":"11","key":"10.1016\/j.injury.2019.08.036_bib0105","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.3390\/ijms11114465","article-title":"Neuroprotective properties of mildronat, a small molecule, in a rat model of Parkinson\u2019s disease","volume":"11","author":"Klusa","year":"2010","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.injury.2019.08.036_bib0110","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10557-009-6179-2","article-title":"Myocardial infarct size-limiting and anti-arrhythmic effects of mildronat orotate in the rat heart","volume":"23","author":"Vilskersts","year":"2009","journal-title":"Cardiovasc Drugs Ther"},{"issue":"8","key":"10.1016\/j.injury.2019.08.036_bib0115","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/1440-1681.12127","article-title":"Elevated vascular \u03b3-butyrobetaine levels attenuate the development of high glucose-induced endothelial dysfunction","volume":"40","author":"Vilskersts","year":"2013","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"10","key":"10.1016\/j.injury.2019.08.036_bib0120","first-page":"525","article-title":"Search for stroke protecting agents in endothelin-1-induced ischemic stroke model in rats","volume":"48","author":"Rumaks","year":"2012","journal-title":"Medicina (Kaunas)"},{"issue":"2","key":"10.1016\/j.injury.2019.08.036_bib0125","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3171\/jns.1994.80.2.0291","article-title":"A new model of diffuse brain injury in rats. Part I: pathophysiology and biomechanics","volume":"80","author":"Marmarou","year":"1994","journal-title":"J Neurosurg"},{"issue":"3","key":"10.1016\/j.injury.2019.08.036_bib0130","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/01.ta.0000209172.75637.db","article-title":"Modified experimental mild traumatic brain injury model","volume":"60","author":"Ucar","year":"2006","journal-title":"J Trauma"},{"issue":"3","key":"10.1016\/j.injury.2019.08.036_bib0135","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.regpep.2006.11.026","article-title":"The protective effect of oxytocin on renal ischemia\/reperfusion injury in rats","volume":"140","author":"Tu\u011ftepe","year":"2007","journal-title":"Regul Pept"},{"issue":"3","key":"10.1016\/j.injury.2019.08.036_bib0140","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/1523-1747.ep12506462","article-title":"Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker","volume":"78","author":"Bradley","year":"1982","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.injury.2019.08.036_bib0145","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/0041-008X(86)90286-3","article-title":"Erythrocyte superoxide dismutase activity and other parameters of copper status in rats ingesting lead acetate","volume":"82","author":"Mylroie","year":"1986","journal-title":"Toxicol Appl Pharmacol"},{"issue":"3","key":"10.1016\/j.injury.2019.08.036_bib0150","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/20014091091797","article-title":"Principles and applications of luminescence spectroscopy","volume":"41","author":"Deshpande","year":"2001","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"4","key":"10.1016\/j.injury.2019.08.036_bib0155","first-page":"593","article-title":"Anti-oxidant property of ethanolic extract of propolis (EEP) as evaluated by inhibiting the chemiluminescence oxidation of luminol","volume":"21","author":"Krol","year":"1990","journal-title":"Biochem Int"},{"issue":"12","key":"10.1016\/j.injury.2019.08.036_bib0160","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S1474-4422(17)30371-X","article-title":"Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research","volume":"16","author":"Maas","year":"2017","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.injury.2019.08.036_bib0165","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1378\/chest.122.2.699","article-title":"Management of head trauma","volume":"122","author":"Marik","year":"2002","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.injury.2019.08.036_bib0170","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00701-012-1501-3","article-title":"The protective effect of 2-mercaptoethane sulfonate (MESNA) against traumatic brain injury in rats","volume":"155","author":"Yilmaz","year":"2013","journal-title":"Acta Neurochir (Wien)"},{"issue":"5","key":"10.1016\/j.injury.2019.08.036_bib0175","first-page":"1119","article-title":"Antioxidant and antiapoptotic effects of darbepoetin-\u03b1 against traumatic brain injury in rats","volume":"11","author":"Kertmen","year":"2015","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.injury.2019.08.036_bib0180","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.wneu.2016.09.115","article-title":"Does decorin protect neuronal tissue via its antioxidant and antiinflammatory activity from traumatic brain injury? An experimental study","volume":"97","author":"\u00d6zay","year":"2017","journal-title":"World Neurosurg"},{"issue":"4","key":"10.1016\/j.injury.2019.08.036_bib0185","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/j.1476-5381.2010.01163.x","article-title":"Animal modelling of traumatic brain injury in preclinical drug development: where do we go from here?","volume":"164","author":"Marklund","year":"2011","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.injury.2019.08.036_bib0190","first-page":"289","article-title":"Brain oxygenation and energy metabolism: part I-biological function and pathophysiology","volume":"51","author":"Zauner","year":"2002","journal-title":"Neurosurgery"},{"issue":"2-3","key":"10.1016\/j.injury.2019.08.036_bib0195","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1179\/016164101101198505","article-title":"Cerebral perfusion and blood flow in neurotrauma","volume":"23","author":"Zwienenberg","year":"2001","journal-title":"Neurol Res"},{"issue":"5","key":"10.1016\/j.injury.2019.08.036_bib0200","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3171\/jns.1991.75.5.0685","article-title":"Cerebral circulation and metabolism after severe traumatic brain injury: the elusive role of ischemia","volume":"75","author":"Bouma","year":"1991","journal-title":"J Neurosurg"},{"issue":"12","key":"10.1016\/j.injury.2019.08.036_bib0205","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1089\/neu.2005.22.1411","article-title":"Changes in cerebral blood flow from the acute to the chronic phase of severe head injury","volume":"22","author":"Inoue","year":"2005","journal-title":"J Neurotrauma"},{"issue":"3","key":"10.1016\/j.injury.2019.08.036_bib0210","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/01.fjc.0000211732.76668.d2","article-title":"Mildronat, a novel fatty acid oxidation inhibitor and antianginal agent, reduces myocardial infarct size without affecting hemodynamics","volume":"47","author":"Sesti","year":"2006","journal-title":"J Cardiovasc Pharmacol"},{"issue":"5","key":"10.1016\/j.injury.2019.08.036_bib0215","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1517\/13543784.11.5.615","article-title":"Partial fatty acid oxidation inhibitors for stable angina","volume":"11","author":"Stanley","year":"2002","journal-title":"Expert Opin Investig Drugs"},{"issue":"10","key":"10.1016\/j.injury.2019.08.036_bib0220","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s40261-013-0121-x","article-title":"Efficacy and safety of mildronat for acute ischemic stroke: a randomized, double-blind, active-controlled phase II multicenter trial","volume":"33","author":"Zhu","year":"2013","journal-title":"Clin Drug Investig"},{"issue":"6","key":"10.1016\/j.injury.2019.08.036_bib0225","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/01.fjc.0000250077.07702.23","article-title":"Mildronat, an inhibitor of carnitine biosynthesis, induces an increase in gamma butyrobetaine contents and cardioprotection in isolated rat heart infarction","volume":"48","author":"Liepinsh","year":"2006","journal-title":"J Cardiovasc Pharmacol"},{"issue":"9","key":"10.1016\/j.injury.2019.08.036_bib0230","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/j.2042-7158.2011.01325.x","article-title":"Mildronat treatment alters \u03b3-butyrobetaine and l-carnitine concentrations in healthy volunteers","volume":"63","author":"Liepinsh","year":"2011","journal-title":"J Pharm Pharmacol"},{"issue":"1","key":"10.1016\/j.injury.2019.08.036_bib0235","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1742-7843.2004.pto_940108.x","article-title":"Effects of gamma-butyrobetaine and mildronat on nitric oxide production in lipopolysaccharide treated rats","volume":"94","author":"Sjakste","year":"2004","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"1","key":"10.1016\/j.injury.2019.08.036_bib0240","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejphar.2004.05.006","article-title":"Endothelium- and nitric oxide-dependent vasorelaxing activities of gamma butyrobetaine esters: possible link to the antiischemic activities of mildronat","volume":"495","author":"Sjakste","year":"2004","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"10.1016\/j.injury.2019.08.036_bib0245","first-page":"301","article-title":"Mildronat and its neuroregulatory mechanisms: targeting the mitochondria, neuroinflammation, and protein expression","volume":"49","author":"Klusa","year":"2013","journal-title":"Medicina (Kaunas)"},{"issue":"13","key":"10.1016\/j.injury.2019.08.036_bib0250","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/978-3-211-75718-5_88","article-title":"Vasospasm in traumatic brain injury","volume":"104","author":"Armin","year":"2008","journal-title":"Acta Neurochir Suppl"},{"key":"10.1016\/j.injury.2019.08.036_bib0255","first-page":"13","article-title":"Mildronat: mechanisms of action, perspective for pathology correction","volume":"29","author":"ZhV","year":"1995","journal-title":"Khim-Pharm Zh"},{"key":"10.1016\/j.injury.2019.08.036_bib0260","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/10604450213832","article-title":"Involvement of nitric oxide production in the mildronat mechanism of action","volume":"12","author":"Dzintare","year":"2002","journal-title":"Pharmacol Rev Commun"},{"issue":"8","key":"10.1016\/j.injury.2019.08.036_bib0265","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18081788","article-title":"The role of neurogenic inflammation in blood-brain barrier disruption and development of cerebral oedema following acute central nervous system (CNS) injury","volume":"18","author":"Sorby-Adams","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.injury.2019.08.036_bib0270","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/bja\/aem131","article-title":"Pathophysiology of traumatic brain injury","volume":"99","author":"Werner","year":"2007","journal-title":"Br J Anaesth"},{"issue":"1-3","key":"10.1016\/j.injury.2019.08.036_bib0275","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejphar.2013.05.012","article-title":"The protective effect of low-dose methotrexate on ischemia-reperfusion injury of the rabbit spinal cord","volume":"714","author":"Kertmen","year":"2013","journal-title":"Eur J Pharmacol"},{"issue":"Pt 3","key":"10.1016\/j.injury.2019.08.036_bib0280","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1042\/bj3610417","article-title":"Carnitine biosynthesis in mammals","volume":"361","author":"Vaz","year":"2002","journal-title":"Biochem J"},{"key":"10.1016\/j.injury.2019.08.036_bib0285","first-page":"77","article-title":"The efficacy of the mildronat treatment of patients with ischemic stroke","volume":"7","author":"Vinichuk","year":"1991","journal-title":"Vrach Delo"},{"issue":"4","key":"10.1016\/j.injury.2019.08.036_bib0290","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S0306-4522(97)00011-0","article-title":"Role of neutrophils in spinal cord injury in the rat","volume":"79","author":"Taoka","year":"1997","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.injury.2019.08.036_bib0295","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.injury.2014.11.002","article-title":"Neuroprotective effects of testosterone on ischemia\/reperfusion injury of the rabbit spinal cord","volume":"46","author":"G\u00fcrer","year":"2015","journal-title":"Injury"},{"issue":"11","key":"10.1016\/j.injury.2019.08.036_bib0300","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1016\/j.injury.2015.08.017","article-title":"Neuroprotective effects of Ganoderma lucidum polysaccharides against traumatic spinal cord injury in rats","volume":"46","author":"Gokce","year":"2015","journal-title":"Injury"},{"issue":"2","key":"10.1016\/j.injury.2019.08.036_bib0305","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0301-0082(03)00005-4","article-title":"To die or not to die for neurons in ischemia, traumatic brain injury and epilepsy: a review on the stress-activated signaling pathways and apoptotic pathways","volume":"69","author":"Liou","year":"2003","journal-title":"Prog Neurobiol"},{"issue":"1","key":"10.1016\/j.injury.2019.08.036_bib0310","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1046\/j.1471-4159.2002.00975.x","article-title":"Intranuclear localization of apoptosis-inducing factor (AIF) and large scale DNA fragmentation after traumatic brain injury in rats and in neuronal cultures exposed to peroxynitrite","volume":"82","author":"Zhang","year":"2002","journal-title":"J Neurochem"},{"issue":"5","key":"10.1016\/j.injury.2019.08.036_bib0315","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/jnen\/60.5.422","article-title":"Apoptotic and anti-apoptotic mechanisms following spinal cord injury","volume":"60","author":"Keane","year":"2001","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"10.1016\/j.injury.2019.08.036_bib0320","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1067\/mtc.2003.112","article-title":"Survival and death promoting events after transient spinal cord ischemia in rabbits: induction of Akt and caspase 3 in motor neurons","volume":"125","author":"Sakurai","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"6","key":"10.1016\/j.injury.2019.08.036_bib0325","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00701-012-1298-0","article-title":"Effects of darbepoetin-\u03b1 in spinal cord ischemia-reperfusion injury in the rabbit","volume":"154","author":"Yilmaz","year":"2012","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.injury.2019.08.036_bib0330","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3389\/fncel.2014.00429","article-title":"Diffuse axonal injury in brain trauma: insights from alterations in neurofilaments","volume":"8","author":"Siedler","year":"2014","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"10.1016\/j.injury.2019.08.036_bib0335","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.nurt.2009.10.021","article-title":"Antioxidant therapies for traumatic brain injury","volume":"7","author":"Hall","year":"2010","journal-title":"Neurotherapeutics"},{"issue":"6","key":"10.1016\/j.injury.2019.08.036_bib0340","doi-asserted-by":"crossref","first-page":"631","DOI":"10.33549\/physiolres.930709","article-title":"Effect of melatonin on brain oxidative damage induced by traumatic brain injury in immature rats","volume":"54","author":"Ozdemir","year":"2005","journal-title":"Physiol Res"},{"issue":"3","key":"10.1016\/j.injury.2019.08.036_bib0345","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/oxfordjournals.bmb.a072632","article-title":"Free radicals in brain metabolism and pathology","volume":"49","author":"Evans","year":"1993","journal-title":"Br Med Bull"},{"issue":"1","key":"10.1016\/j.injury.2019.08.036_bib0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1600-079X.2003.00092.x","article-title":"Regulation of antioxidant enzymes: a significant role for melatonin","volume":"36","author":"Rodriguez","year":"2004","journal-title":"J Pineal Res"},{"issue":"1","key":"10.1016\/j.injury.2019.08.036_bib0355","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/00005373-200107000-00004","article-title":"Effects of deferoxamine on tissue superoxide dismutase and glutathione peroxidase levels in experimental head trauma","volume":"51","author":"Erkan Ust\u00fcn","year":"2001","journal-title":"J Trauma"},{"key":"10.1016\/j.injury.2019.08.036_bib0360","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.wneu.2017.04.136","article-title":"The Protective Effect of Omeprazole Against Traumatic Brain Injury: An Experimental Study","volume":"104","author":"\u00d6zay","year":"2017","journal-title":"World Neurosurg"}],"container-title":["Injury"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0020138319305091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0020138319305091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T14:15:47Z","timestamp":1762179347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0020138319305091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":72,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0020138319305091"],"URL":"https:\/\/doi.org\/10.1016\/j.injury.2019.08.036","relation":{},"ISSN":["0020-1383"],"issn-type":[{"value":"0020-1383","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroprotective effects of mildronate in a rat model of traumatic brain injury","name":"articletitle","label":"Article Title"},{"value":"Injury","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.injury.2019.08.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}